Bjorn H. Ostenstad
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.
Journal: British journal of haematology
Published: February 04, 2026
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
Journal: Haematologica
Published: February 01, 2024
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
Journal: Blood advances
Published: March 08, 2023
Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data.
Journal: Leukemia & lymphoma
Published: November 07, 2022
Rettigheter og tvang i kommunale hjelpetilbud til personer med alvorlige samtidige rus- og psykiske lidelser: erfaringer med regelverket, i lys av menneskerettigheter.
Journal: Nordisk alkohol- & narkotikatidskrift : NAT
Published: September 22, 2022
New legislation on involuntary psychiatric admission – some clarifications.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: November 23, 2021
The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.
Journal: British journal of haematology
Published: January 12, 2020
Magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in neurolymphomatosis: an uncommon presentation of diffuse large B cell lymphoma.
Journal: Annals of hematology
Published: October 19, 2019
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Journal: British journal of haematology
Published: June 04, 2019
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.
Journal: British journal of haematology
Published: March 18, 2019
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.
Journal: Haematologica
Published: March 09, 2019
Last Updated: 09/26/2026